ZeaONE Zeaxanthin Approved For Sale in Brazil

Article

ANVISA, Brazil’s Health Surveillance Agency, has approved sale of Kemin’s ZeaONE.

Photo ©iStockphoto.com/geopaul

Photo ©iStockphoto.com/geopaul

ANVISA, Brazil’s Health Surveillance Agency, has approved for sale ZeaONE Zeaxanthin from Kemin Health LC (Des Moines,IA). The news allows Kemin to begin immediate marketing in Brazil of ZeaONE, a zeaxanthin ingredient sourced from a parented line of marigolds.

Like lutein, zeaxanthin has shown promise for health conditions like skin health and eye health in multiple scientific studies. In a recent age-related eye disease study from the U.S. National Eye Institute (AREDS2), 2 mg of zeaxanthin plus 10 mg of Kemin’s FloraGLO lutein was found to “slow the progression of age-related macular degeneration.”

ZeaONE is commercially available under the OptiSharp Natural brand from DSM (Parsippany, NJ).

 

Read more:

Fierce Debate over Zeaxanthin Isomers

Lutein and Zeaxanthin Benefit Young and Old Alike

 

Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com

Recent Videos
woman working on laptop computer by window
Related Content
© 2024 MJH Life Sciences

All rights reserved.